{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:49:45Z","timestamp":1792511385591,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11427-024-2851-4","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:34:40Z","timestamp":1749083680000},"page":"3436-3449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bioprofiling and vaccine development for Zika virus"],"prefix":"10.1007","volume":"68","author":[{"given":"Huiping","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"2851_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"P Abbink","year":"2016","unstructured":"Abbink, P., Larocca, R.A., De La Barrera, R.A., Bricault, C.A., Moseley, E.T., Boyd, M., Kirilova, M., Li, Z., Ng\u2019ang\u2019a, D., Nanayakkara, O., et al. (2016). Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353, 1129\u20131132.","journal-title":"Science"},{"key":"2851_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.12656","volume":"149","author":"A Alam","year":"2016","unstructured":"Alam, A., Ali, S., Ahamad, S., Malik, M.Z., and Ishrat, R. (2016). From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein. Immunology 149, 386\u2013399.","journal-title":"Immunology"},{"key":"2851_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41598-021-03990-6","volume":"12","author":"ACB Antonelli","year":"2022","unstructured":"Antonelli, A.C.B., Almeida, V.P., de Castro, F.O.F., Silva, J.M., Pfrimer, I.A.H., Cunha-Neto, E., Maranh\u00e3o, A.Q., Br\u00edgido, M.M., Resende, R.O., Bocca, A.L., et al. (2022). In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools. Sci Rep 12, 53.","journal-title":"Sci Rep"},{"key":"2851_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41598-020-57545-2","volume":"10","author":"G \u00c1vila-P\u00e9rez","year":"2020","unstructured":"\u00c1vila-P\u00e9rez, G., Nogales, A., Park, J.G., Vasquez, D.M., Dean, D.A., Barravecchia, M., Perez, D.R., Almaz\u00e1n, F., and Mart\u00ednez-Sobrido, L. (2020). In vivo rescue of recombinant Zika virus from an infectious cDNA clone and its implications in vaccine development. Sci Rep 10, 512.","journal-title":"Sci Rep"},{"key":"2851_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","volume":"20","author":"RE Baker","year":"2022","unstructured":"Baker, R.E., Mahmud, A.S., Miller, I.F., Rajeev, M., Rasambainarivo, F., Rice, B.L., Takahashi, S., Tatem, A.J., Wagner, C.E., Wang, L.F., et al. (2022). Infectious disease in an era of global change. Nat Rev Microbiol 20, 193\u2013205.","journal-title":"Nat Rev Microbiol"},{"key":"2851_CR6","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.vaccine.2018.01.056","volume":"36","author":"R Basu","year":"2018","unstructured":"Basu, R., Zhai, L., Contreras, A., and Tumban, E. (2018). Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells. Vaccine 36, 1256\u20131264.","journal-title":"Vaccine"},{"key":"2851_CR7","doi-asserted-by":"publisher","first-page":"e0005608","DOI":"10.1371\/journal.pntd.0005608","volume":"11","author":"H Boigard","year":"2017","unstructured":"Boigard, H., Alimova, A., Martin, G.R., Katz, A., Gottlieb, P., Galarza, J.M., and Kading, R.C. (2017). Zika virus-like particle (VLP) based vaccine. PLoS Negl Trop Dis 11, e0005608.","journal-title":"PLoS Negl Trop Dis"},{"key":"2851_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41541-023-00656-4","volume":"8","author":"B Bollman","year":"2023","unstructured":"Bollman, B., Nunna, N., Bahl, K., Hsiao, C.J., Bennett, H., Butler, S., Foreman, B., Burgomaster, K.E., Aleshnick, M., Kong, W.P., et al. (2023). An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection. npj Vaccines 8, 58.","journal-title":"npj Vaccines"},{"key":"2851_CR9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/sj.emboj.7600064","volume":"23","author":"S Bressanelli","year":"2004","unstructured":"Bressanelli, S., Stiasny, K., Allison, S.L., Stura, E.A., Duquerroy, S., Lescar, J., Heinz, F. X., and Rey, F.A. (2004). Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23, 728\u2013738.","journal-title":"EMBO J"},{"key":"2851_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9591670","volume":"2021","author":"SNH Bukhari","year":"2021","unstructured":"Bukhari, S.N.H., Jain, A., Haq, E., Khder, M.A., Neware, R., Bhola, J., Lari Najafi, M., and Chakraborty, C. (2021). Machine learning-based ensemble model for Zika virus T-cell epitope prediction. J Healthc Eng 2021, 1\u201310.","journal-title":"J Healthc Eng"},{"key":"2851_CR11","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1038\/s41598-020-60238-5","volume":"10","author":"BL Bullard","year":"2020","unstructured":"Bullard, B.L., Corder, B.N., Gordon, D.N., Pierson, T.C., and Weaver, E.A. (2020). Characterization of a species E adenovirus vector as a Zika virus vaccine. Sci Rep 10, 3613.","journal-title":"Sci Rep"},{"key":"2851_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/infdis\/jiab185","volume":"224","author":"KE Burgomaster","year":"2021","unstructured":"Burgomaster, K.E., Foreman, B.M., Aleshnick, M.A., Larman, B.C., Gordon, D.N., Maciejewski, S., Morabito, K.M., Ledgerwood, J.E., Gaudinski, M.R., Chen, G.L., et al. (2021). Limited flavivirus cross-reactive antibody responses elicited by a Zika virus deoxyribonucleic acid vaccine candidate in humans. J Infect Dis 224, 1550\u20131555.","journal-title":"J Infect Dis"},{"key":"2851_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","volume":"16","author":"G Calvet","year":"2016","unstructured":"Calvet, G., Aguiar, R.S., Melo, A.S.O., Sampaio, S.A., de Filippis, I., Fabri, A., Araujo, E.S.M., de Sequeira, P.C., de Mendon\u00e7a, M.C.L., de Oliveira, L., et al. (2016). Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 16, 653\u2013660.","journal-title":"Lancet Infect Dis"},{"key":"2851_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.micinf.2010.10.011","volume":"13","author":"Z Chen","year":"2011","unstructured":"Chen, Z., Lin, X., Zhang, Z., Huang, J., Fu, S., and Huang, R. (2011). EXO70 protein influences dengue virus secretion. Microbes Infect 13, 143\u2013150.","journal-title":"Microbes Infect"},{"key":"2851_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41590-021-00966-6","volume":"22","author":"L Dai","year":"2021","unstructured":"Dai, L., Xu, K., Li, J., Huang, Q., Song, J., Han, Y., Zheng, T., Gao, P., Lu, X., Yang, H., et al. (2021). Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch. Nat Immunol 22, 958\u2013968.","journal-title":"Nat Immunol"},{"key":"2851_CR16","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/vaccines11071250","volume":"11","author":"HL Dong","year":"2023","unstructured":"Dong, H.L., He, M.J., Wang, Q.Y., Cui, J.Z., Chen, Z.L., Xiong, X.H., Zhang, L.C., Cheng, H., Xiong, G.Q., Hu, A., et al. (2023). Rapid generation of recombinant flaviviruses using circular polymerase extension reaction. Vaccines 11, 1250.","journal-title":"Vaccines"},{"key":"2851_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","volume":"354","author":"KA Dowd","year":"2016","unstructured":"Dowd, K.A., Ko, S.Y., Morabito, K.M., Yang, E.S., Pelc, R.S., DeMaso, C.R., Castilho, L. R., Abbink, P., Boyd, M., Nityanandam, R., et al. (2016). Rapid development of a DNA vaccine for Zika virus. Science 354, 237\u2013240.","journal-title":"Science"},{"key":"2851_CR18","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"MR Duffy","year":"2009","unstructured":"Duffy, M.R., Chen, T.H., Hancock, W.T., Powers, A.M., Kool, J.L., Lanciotti, R.S., Pretrick, M., Marfel, M., Holzbauer, S., Dubray, C., et al. (2009). Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360, 2536\u20132543.","journal-title":"N Engl J Med"},{"key":"2851_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1017\/S0022172400025997","volume":"83","author":"AH Fagbami","year":"1979","unstructured":"Fagbami, A.H. (1979). Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg 83, 213\u2013219.","journal-title":"J Hyg"},{"key":"2851_CR20","doi-asserted-by":"publisher","first-page":"e00834-17","DOI":"10.1128\/JVI.00834-17","volume":"91","author":"H Garg","year":"2017","unstructured":"Garg, H., Sedano, M., Plata, G., Punke, E.B., Joshi, A., and Diamond, M.S. (2017). Development of virus-like-particle vaccine and reporter assay for zika virus. J Virol 91, e00834-17.","journal-title":"J Virol"},{"key":"2851_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12865-020-00389-2","volume":"22","author":"H Garg","year":"2021","unstructured":"Garg, H., Yeh, R., Watts, D.M., Mehmetoglu-Gurbuz, T., Resendes, R., Parsons, B., Gonzales, F., and Joshi, A. (2021). Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection. BMC Immunol 22, 5.","journal-title":"BMC Immunol"},{"key":"2851_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathmechdis-031521-034739","volume":"18","author":"MI Giraldo","year":"2023","unstructured":"Giraldo, M.I., Gonzalez-Orozco, M., and Rajsbaum, R. (2023). Pathogenesis of Zika virus infection. Annu Rev Pathol Mech Dis 18, 181\u2013203.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2851_CR23","first-page":"e136","volume":"41","author":"G Gonzalez-Escobar","year":"2018","unstructured":"Gonzalez-Escobar, G., Marie Valadere, A., Adams, R., Polson-Edwards, K., Hinds, A.Q. J., Misir, A., and Hospedales, C.J. (2018). Prolonged Zika virus viremia in a patient with Guillain-Barr\u00e9 syndrome in Trinidad and Tobago. Rev Panam Salud P\u00fablica 41, e136.","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"2851_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.chembiol.2022.02.004","volume":"29","author":"GI Georgiev","year":"2022","unstructured":"Georgiev, G.I., Malonis, R.J., Wirchnianski, A.S., Wessel, A.W., Jung, H.S., Cahill, S. M., Nyakatura, E.K., Vergnolle, O., Dowd, K.A., Cowburn, D., et al. (2022). Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo. Cell Chem Biol 29, 811\u2013823.e7.","journal-title":"Cell Chem Biol"},{"key":"2851_CR25","doi-asserted-by":"publisher","first-page":"S860","DOI":"10.1093\/infdis\/jix451","volume":"216","author":"DJ Gubler","year":"2017","unstructured":"Gubler, D.J., Vasilakis, N., and Musso, D. (2017). History and emergence of Zika virus. J Infect Dis 216, S860\u2013S867.","journal-title":"J Infect Dis"},{"key":"2851_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/infdis\/jiy187","volume":"218","author":"Q Guo","year":"2018","unstructured":"Guo, Q., Chan, J.F.W., Poon, V.K.M., Wu, S., Chan, C.C.S., Hou, L., Yip, C.C.Y., Ren, C., Cai, J.P., Zhao, M., et al. (2018). Immunization with a novel human type 5 adenovirus-vectored vaccine expressing the premembrane and envelope proteins of Zika virus provides consistent and sterilizing protection in multiple immunocompetent and immunocompromised animal models. J Infect Dis 218, 365\u2013377.","journal-title":"J Infect Dis"},{"key":"2851_CR27","doi-asserted-by":"publisher","first-page":"110761","DOI":"10.1016\/j.humimm.2024.110761","volume":"85","author":"Y Gupta","year":"2024","unstructured":"Gupta, Y., Baranwal, M., and Chudasama, B. (2024). Zika virus precursor membrane peptides induce immune response in peripheral blood mononuclear cells. Hum Immunol 85, 110761.","journal-title":"Hum Immunol"},{"key":"2851_CR28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/S1473-3099(20)30733-7","volume":"21","author":"HH Han","year":"2021","unstructured":"Han, H.H., Diaz, C., Acosta, C.J., Liu, M., and Borkowski, A. (2021). Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: An observer-blind, randomised, phase 1 trial. Lancet Infect Dis 21, 1282\u20131292.","journal-title":"Lancet Infect Dis"},{"key":"2851_CR29","doi-asserted-by":"publisher","first-page":"100434","DOI":"10.1016\/j.imu.2020.100434","volume":"21","author":"MT Haque","year":"2020","unstructured":"Haque, M.T., Shah, M.N.A., Paul, S., Khan, M.K., and Barua, P. (2020). Zika viral proteome analysis reveals an epitope cluster within NS3 helicase as a potential vaccine candidate: an in silico study. Inf Med Unlocked 21, 100434.","journal-title":"Inf Med Unlocked"},{"key":"2851_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41421-018-0017-2","volume":"4","author":"Y Huang","year":"2018","unstructured":"Huang, Y., Li, Y., Zhang, H., Zhao, R., Jing, R., Xu, Y., He, M., Peer, J., Kim, Y.C., Luo, J., et al. (2018). Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869. Cell Discov 4, 19.","journal-title":"Cell Discov"},{"key":"2851_CR31","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.2174\/0929867326666190111115132","volume":"27","author":"P Karwal","year":"2020","unstructured":"Karwal, P., Vats, I.D., Sinha, N., Singhal, A., Sehgal, T., and Kumari, P. (2020). Therapeutic applications of peptides against Zika virus: a review. Curr Med Chem 27, 3906\u20133923.","journal-title":"Curr Med Chem"},{"key":"2851_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fimmu.2018.00597","volume":"9","author":"R Khandia","year":"2018","unstructured":"Khandia, R., Munjal, A., Dhama, K., Karthik, K., Tiwari, R., Malik, Y.S., Singh, R.K., and Chaicumpa, W. (2018). Modulation of dengue\/Zika virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in Zika virus infection. Front Immunol 9, 597.","journal-title":"Front Immunol"},{"key":"2851_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41541-024-00823-1","volume":"9","author":"IJ Kim","year":"2024","unstructured":"Kim, I.J., Tighe, M.P., Lanthier, P.A., Clark, M.J., De La Barrera, R.A., Dussupt, V., Mendez-Rivera, L., Krebs, S.J., Travis, K.L., Low-Beer, T.C., et al. (2024). Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice. npj Vaccines 9, 32.","journal-title":"npj Vaccines"},{"key":"2851_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1021\/acs.biochem.6b01056","volume":"56","author":"SY Kim","year":"2017","unstructured":"Kim, S.Y., Zhao, J., Liu, X., Fraser, K., Lin, L., Zhang, X., Zhang, F., Dordick, J.S., and Linhardt, R.J. (2017). Interaction of Zika virus envelope protein with glycosami-noglycans. Biochemistry 56, 1151\u20131162.","journal-title":"Biochemistry"},{"key":"2851_CR35","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3390\/v14122776","volume":"14","author":"T Langerak","year":"2022","unstructured":"Langerak, T., Mumtaz, N., Koopmans, M., Schoenmakers, S., and Rockx, B. (2022). Comparative analysis of in vitro models to study antibody-dependent enhancement of Zika virus infection. Viruses 14, 2776.","journal-title":"Viruses"},{"key":"2851_CR36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R.A., Abbink, P., Peron, J.P.S., de A. Zanotto, P.M., Iampietro, M.J., Badamchi-Zadeh, A., Boyd, M., Ng\u2019Ang\u2019A, D., Kirilova, M., Nityanandam, R., et al. (2016). Vaccine protection against Zika virus from Brazil. Nature 536, 474\u2013478.","journal-title":"Nature"},{"key":"2851_CR37","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","volume":"90","author":"HM Lazear","year":"2016","unstructured":"Lazear, H.M., and Diamond, M.S. (2016). Zika virus: new clinical syndromes and its emergence in the western hemisphere. J Virol 90, 4864\u20134875.","journal-title":"J Virol"},{"key":"2851_CR38","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/s41467-018-05276-4","volume":"9","author":"A Li","year":"2018","unstructured":"Li, A., Yu, J., Lu, M., Ma, Y., Attia, Z., Shan, C., Xue, M., Liang, X., Craig, K., Makadiya, N., et al. (2018a). A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein. Nat Commun 9, 3067.","journal-title":"Nat Commun"},{"key":"2851_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41541-019-0143-3","volume":"4","author":"G Li","year":"2019","unstructured":"Li, G., Adam, A., Luo, H., Shan, C., Cao, Z., Fontes-Garfias, C.R., Sarathy, V.V., Teleki, C., Winkelmann, E.R., Liang, Y., et al. (2019). An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses. npj Vaccines 4, 48.","journal-title":"npj Vaccines"},{"key":"2851_CR40","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","volume":"73","author":"H Li","year":"1999","unstructured":"Li, H., Clum, S., You, S., Ebner, K.E., and Padmanabhan, R. (1999). The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol 73, 3108\u20133116.","journal-title":"J Virol"},{"key":"2851_CR41","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1038\/s41467-020-19028-w","volume":"11","author":"MY Li","year":"2020","unstructured":"Li, M.Y., Naik, T.S., Siu, L.Y.L., Acuto, O., Spooner, E., Wang, P., Yang, X., Lin, Y., Bruzzone, R., Ashour, J., et al. (2020). Lyn kinase regulates egress of flaviviruses in autophagosome-derived organelles. Nat Commun 11, 5189.","journal-title":"Nat Commun"},{"key":"2851_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41467-018-02975-w","volume":"9","author":"XF Li","year":"2018","unstructured":"Li, X.F., Dong, H.L., Wang, H.J., Huang, X.Y., Qiu, Y.F., Ji, X., Ye, Q., Li, C., Liu, Y., Deng, Y.Q., et al. (2018b). Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nat Commun 9, 673.","journal-title":"Nat Commun"},{"key":"2851_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biotechadv.2017.09.004","volume":"36","author":"HH Lin","year":"2018","unstructured":"Lin, H.H., Yip, B.S., Huang, L.M., and Wu, S.C. (2018). Zika virus structural biology and progress in vaccine development. Biotechnol Adv 36, 47\u201353.","journal-title":"Biotechnol Adv"},{"key":"2851_CR44","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1038\/s41467-018-04859-5","volume":"9","author":"C L\u00f3pez-Camacho","year":"2018","unstructured":"L\u00f3pez-Camacho, C., Abbink, P., Larocca, R.A., Dejnirattisai, W., Boyd, M., Badamchi-Zadeh, A., Wallace, Z.R., Doig, J., Velazquez, R.S., Neto, R.D.L., et al. (2018). Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors. Nat Commun 9, 2441.","journal-title":"Nat Commun"},{"key":"2851_CR45","doi-asserted-by":"publisher","first-page":"eaba5068","DOI":"10.1126\/sciadv.aba5068","volume":"6","author":"K Luisi","year":"2020","unstructured":"Luisi, K., Morabito, K.M., Burgomaster, K.E., Sharma, M., Kong, W.P., Foreman, B.M., Patel, S., Fisher, B., Aleshnick, M.A., Laliberte, J., et al. (2020). Development of a potent Zika virus vaccine using self-amplifying messenger RNA. Sci Adv 6, eaba5068.","journal-title":"Sci Adv"},{"key":"2851_CR46","doi-asserted-by":"publisher","first-page":"taad154","DOI":"10.1093\/jtm\/taad154","volume":"31","author":"BM McClenathan","year":"2024","unstructured":"McClenathan, B.M., Taylor, J.N., Housel, L.A., and Ryan, M. (2024). Incidence of anaphylaxis to YF-VAX\u00ae yellow fever vaccination: a retrospective evaluation of vaccine adverse event reports 1999\u20132018. J Travel Med 31, taad154.","journal-title":"J Travel Med"},{"key":"2851_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Y Modis","year":"2004","unstructured":"Modis, Y., Ogata, S., Clements, D., and Harrison, S.C. (2004). Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313\u2013319.","journal-title":"Nature"},{"key":"2851_CR48","doi-asserted-by":"publisher","first-page":"e00278-18","DOI":"10.1128\/mSphere.00278-18","volume":"3","author":"A Moreira-Soto","year":"2018","unstructured":"Moreira-Soto, A., Cabral, R., Pedroso, C., Eschbach-Bludau, M., Rockstroh, A., Vargas, L.A., Postigo-Hidalgo, I., Luz, E., Sampaio, G.S., Drosten, C., et al. (2018). Exhaustive TORCH pathogen diagnostics corroborate Zika virus etiology of congenital malformations in northeastern Brazil. mSphere 3, e00278-18.","journal-title":"mSphere"},{"key":"2851_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41564-022-01289-4","volume":"8","author":"RP Olmo","year":"2023","unstructured":"Olmo, R.P., Todjro, Y.M.H., Aguiar, E.R.G.R., de Almeida, J.P.P., Ferreira, F.V., Armache, J.N., de Faria, I.J.S., Ferreira, A.G.A., Amadou, S.C.G., Silva, A.T.S., et al. (2023). Mosquito vector competence for dengue is modulated by insect-specific viruses. Nat Microbiol 8, 135\u2013149.","journal-title":"Nat Microbiol"},{"key":"2851_CR50","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fcimb.2018.00388","volume":"8","author":"JF Osuna-Ramos","year":"2018","unstructured":"Osuna-Ramos, J.F., Reyes-Ruiz, J.M., and del \u00c1ngel, R.M. (2018). The role of host cholesterol during flavivirus infection. Front Cell Infect Microbiol 8, 388.","journal-title":"Front Cell Infect Microbiol"},{"key":"2851_CR51","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2105\/AJPH.2016.303112","volume":"106","author":"ES Paix\u00e3o","year":"2016","unstructured":"Paix\u00e3o, E.S., Barreto, F., da Gl\u00f3ria Teixeira, M., da Concei\u00e7\u00e3o N. Costa, M., and Rodrigues, L.C. (2016). History, epidemiology, and clinical manifestations of Zika: a systematic review. Am J Public Health 106, 606\u2013612.","journal-title":"Am J Public Health"},{"key":"2851_CR52","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3201\/eid2208.160496","volume":"22","author":"IAD Paploski","year":"2016","unstructured":"Paploski, I.A.D., Prates, A.P.P.B., Cardoso, C.W., Kikuti, M., Silva, M.M.O., Waller, L. A., Reis, M.G., Kitron, U., and Ribeiro, G.S. (2016). Time lags between exanthematous illness attributed to Zika virus, Guillain-Barr\u00e9 syndrome, and microcephaly, salvador, Brazil. Emerg Infect Dis 22, 1438\u20131444.","journal-title":"Emerg Infect Dis"},{"key":"2851_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","volume":"543","author":"N Pardi","year":"2017","unstructured":"Pardi, N., Hogan, M.J., Pelc, R.S., Muramatsu, H., Andersen, H., DeMaso, C.R., Dowd, K.A., Sutherland, L.L., Scearce, R.M., Parks, R., et al. (2017). Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543, 248\u2013251.","journal-title":"Nature"},{"key":"2851_CR54","doi-asserted-by":"publisher","first-page":"122331","DOI":"10.1016\/j.lfs.2023.122331","volume":"336","author":"R Poria","year":"2024","unstructured":"Poria, R., Kala, D., Nagraik, R., Dhir, Y., Dhir, S., Singh, B., Kaushik, N.K., Noorani, M.S., Kaushal, A., and Gupta, S. (2024). Vaccine development: current trends and technologies. Life Sci 336, 122331.","journal-title":"Life Sci"},{"key":"2851_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/22221751.2018.1557988","volume":"8","author":"S Pujhari","year":"2019","unstructured":"Pujhari, S., Brustolin, M., Macias, V.M., Nissly, R.H., Nomura, M., Kuchipudi, S.V., and Rasgon, J.L. (2019). Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells. Emerg Microbes Infects 8, 8\u201316.","journal-title":"Emerg Microbes Infects"},{"key":"2851_CR56","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/jmv.24563","volume":"88","author":"S Ramos da Silva","year":"2016","unstructured":"Ramos da Silva, S., and Gao, S.J. (2016). Zika virus: an update on epidemiology, pathology, molecular biology, and animal model. J Med Virol 88, 1291\u20131296.","journal-title":"J Med Virol"},{"key":"2851_CR57","doi-asserted-by":"publisher","first-page":"eaav3208","DOI":"10.1126\/sciadv.aav3208","volume":"5","author":"APS Rathore","year":"2019","unstructured":"Rathore, A.P.S., Saron, W.A.A., Lim, T., Jahan, N., and St. John, A.L. (2019). Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses. Sci Adv 5, eaav3208.","journal-title":"Sci Adv"},{"key":"2851_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","volume":"170","author":"JM Richner","year":"2017","unstructured":"Richner, J.M., Jagger, B.W., Shan, C., Fontes, C.R., Dowd, K.A., Cao, B., Himansu, S., Caine, E.A., Nunes, B.T.D., Medeiros, D.B.A., et al. (2017). Vaccine mediated protection against Zika virus-induced congenital disease. Cell 170, 273\u2013283.e12.","journal-title":"Cell"},{"key":"2851_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","volume":"169","author":"DF Robbiani","year":"2017","unstructured":"Robbiani, D.F., Bozzacco, L., Keeffe, J.R., Khouri, R., Olsen, P.C., Gazumyan, A., Schaefer-Babajew, D., Avila-Rios, S., Nogueira, L., Patel, R., et al. (2017). Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico. Cell 169, 597\u2013609.e11.","journal-title":"Cell"},{"key":"2851_CR60","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Rold\u00e3o","year":"2010","unstructured":"Rold\u00e3o, A., Mellado, M.C.M., Castilho, L.R., Carrondo, M.J., and Alves, P.M. (2010). Virus-like particles in vaccine development. Expert Rev Vaccines 9, 1149\u20131176.","journal-title":"Expert Rev Vaccines"},{"key":"2851_CR61","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1473-3099(18)30718-7","volume":"19","author":"K Ruchusatsawat","year":"2019","unstructured":"Ruchusatsawat, K., Wongjaroen, P., Posanacharoen, A., Rodriguez-Barraquer, I., Sangkitporn, S., Cummings, D.A.T., and Salje, H. (2019). Long-term circulation of Zika virus in Thailand: an observational study. Lancet Infect Dis 19, 439\u2013446.","journal-title":"Lancet Infect Dis"},{"key":"2851_CR62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","volume":"540","author":"G Sapparapu","year":"2016","unstructured":"Sapparapu, G., Fernandez, E., Kose, N., Fox, J.M., Bombardi, R.G., Zhao, H., Nelson, C. A., Bryan, A.L., Barnes, T., Davidson, E., et al. (2016). Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443\u2013447.","journal-title":"Nature"},{"key":"2851_CR63","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.celrep.2016.06.028","volume":"16","author":"G Savidis","year":"2016","unstructured":"Savidis, G., McDougall, W.M., Meraner, P., Perreira, J.M., Portmann, J.M., Trincucci, G., John, S.P., Aker, A.M., Renzette, N., Robbins, D.R., et al. (2016). Identification of Zika virus and dengue virus dependency factors using functional genomics. Cell Rep 16, 232\u2013246.","journal-title":"Cell Rep"},{"key":"2851_CR64","doi-asserted-by":"publisher","first-page":"104199","DOI":"10.1016\/j.meegid.2020.104199","volume":"80","author":"F Shahid","year":"2020","unstructured":"Shahid, F., Ashfaq, U.A., Javaid, A., and Khalid, H. (2020). Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome. Infect Genet Evol 80, 104199.","journal-title":"Infect Genet Evol"},{"key":"2851_CR65","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"C Shan","year":"2017","unstructured":"Shan, C., Muruato, A.E., Nunes, B.T.D., Luo, H., Xie, X., Medeiros, D.B.A., Wakamiya, M., Tesh, R.B., Barrett, A.D., Wang, T., et al. (2017). A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med 23, 763\u2013767.","journal-title":"Nat Med"},{"key":"2851_CR66","doi-asserted-by":"publisher","first-page":"e00758-19","DOI":"10.1128\/mBio.00758-19","volume":"10","author":"BS Shim","year":"2019","unstructured":"Shim, B.S., Kwon, Y.C., Ricciardi, M.J., Stone, M., Otsuka, Y., Berri, F., Kwal, J.M., Magnani, D.M., Jackson, C.B., Richard, A.S., et al. (2019). Zika virus-immune plasmas from symptomatic and asymptomatic individuals enhance Zika pathogenesis in adult and pregnant mice. mBio 10, e00758-19.","journal-title":"mBio"},{"key":"2851_CR67","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41598-021-04713-7","volume":"12","author":"M Shin","year":"2022","unstructured":"Shin, M., Kim, K., Lee, H.J., Lee, R., Jung, Y.J., Park, J., and Hahn, T.W. (2022). Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice. Sci Rep 12, 660.","journal-title":"Sci Rep"},{"key":"2851_CR68","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","volume":"20","author":"JL Slon-Campos","year":"2019","unstructured":"Slon-Campos, J.L., Dejnirattisai, W., Jagger, B.W., L\u00f3pez-Camacho, C., Wongwiwat, W., Durnell, L.A., Winkler, E.S., Chen, R.E., Reyes-Sandoval, A., Rey, F.A., et al. (2019). A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection. Nat Immunol 20, 1291\u20131298.","journal-title":"Nat Immunol"},{"key":"2851_CR69","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/s41467-020-16086-y","volume":"11","author":"A Slonchak","year":"2020","unstructured":"Slonchak, A., Hugo, L.E., Freney, M.E., Hall-Mendelin, S., Amarilla, A.A., Torres, F.J., Setoh, Y.X., Peng, N.Y.G., Sng, J.D.J., Hall, R.A., et al. (2020). Zika virus noncoding RNA suppresses apoptosis and is required for virus transmission by mosquitoes. Nat Commun 11, 2205.","journal-title":"Nat Commun"},{"key":"2851_CR70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2017.03.001","volume":"308","author":"BH Song","year":"2017","unstructured":"Song, B.H., Yun, S.I., Woolley, M., and Lee, Y.M. (2017). Zika virus: history, epidemiology, transmission, and clinical presentation. J Neuroimmunol 308, 50\u201364.","journal-title":"J Neuroimmunol"},{"key":"2851_CR71","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1038\/s41467-020-17638-y","volume":"11","author":"M Srivastava","year":"2020","unstructured":"Srivastava, M., Zhang, Y., Chen, J., Sirohi, D., Miller, A., Zhang, Y., Chen, Z., Lu, H., Xu, J., Kuhn, R.J., et al. (2020). Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor. Nat Commun 11, 3896.","journal-title":"Nat Commun"},{"key":"2851_CR72","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K., Beltramello, M., Espinosa, D.A., Graham, V., Cassotta, A., Bianchi, S., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., et al. (2016). Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826.","journal-title":"Science"},{"key":"2851_CR73","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/v15051156","volume":"15","author":"H Sun","year":"2023","unstructured":"Sun, H., Yang, M., Lai, H., Neupane, B., Teh, A.Y.H., Jugler, C., Ma, J.K.C., Steinkellner, H., Bai, F., and Chen, Q. (2023). A dual-approach strategy to optimize the safety and efficacy of anti-Zika virus monoclonal antibody therapeutics. Viruses 15, 1156.","journal-title":"Viruses"},{"key":"2851_CR74","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.celrep.2018.12.095","volume":"26","author":"S Taguwa","year":"2019","unstructured":"Taguwa, S., Yeh, M.T., Rainbolt, T.K., Nayak, A., Shao, H., Gestwicki, J.E., Andino, R., and Frydman, J. (2019). Zika virus dependence on host Hsp70 provides a protective strategy against infection and disease. Cell Rep 26, 906\u2013920.e3.","journal-title":"Cell Rep"},{"key":"2851_CR75","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1056\/NEJMoa1708120","volume":"385","author":"P Tebas","year":"2021","unstructured":"Tebas, P., Roberts, C.C., Muthumani, K., Reuschel, E.L., Kudchodkar, S.B., Zaidi, F.I., White, S., Khan, A.S., Racine, T., Choi, H., et al. (2021). Safety and immunogenicity of an anti-Zika virus DNA vaccine. N Engl J Med 385, e35.","journal-title":"N Engl J Med"},{"key":"2851_CR76","doi-asserted-by":"publisher","first-page":"20210232","DOI":"10.1002\/EXP.20210232","volume":"3","author":"PL Truong","year":"2023","unstructured":"Truong, P.L., Yin, Y., Lee, D., and Ko, S.H. (2023). Advancement in COVID-19 detection using nanomaterial-based biosensors. Exploration 3, 20210232.","journal-title":"Exploration"},{"key":"2851_CR77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijregi.2022.08.013","volume":"5","author":"Y Ushijima","year":"2022","unstructured":"Ushijima, Y., Abe, H., Mbadinga, M.J.V.M., Ondo, G.N., Bikangui, R., Agnandji, S.T., Lell, B., and Yasuda, J. (2022). Re-emergence of dengue, chikungunya, and Zika viruses in 2021 after a 10-year gap in Gabon. IJID Reg 5, 68\u201371.","journal-title":"IJID Reg"},{"key":"2851_CR78","doi-asserted-by":"publisher","first-page":"37313","DOI":"10.1038\/srep37313","volume":"6","author":"M Usman Mirza","year":"2016","unstructured":"Usman Mirza, M., Rafique, S., Ali, A., Munir, M., Ikram, N., Manan, A., Salo-Ahen, O.M.H., and Idrees, M. (2016). Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins. Sci Rep 6, 37313.","journal-title":"Sci Rep"},{"key":"2851_CR79","doi-asserted-by":"publisher","first-page":"eaay2736","DOI":"10.1126\/scitranslmed.aay2736","volume":"11","author":"KKA Van Rompay","year":"2019","unstructured":"Van Rompay, K.K.A., Keesler, R.I., Ardeshir, A., Watanabe, J., Usachenko, J., Singapuri, A., Cruzen, C., Bliss-Moreau, E., Murphy, A.M., Yee, J.A.L., et al. (2019). DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes. Sci Transl Med 11, eaay2736.","journal-title":"Sci Transl Med"},{"key":"2851_CR80","doi-asserted-by":"publisher","first-page":"e0009195","DOI":"10.1371\/journal.pntd.0009195","volume":"15","author":"L Vang","year":"2021","unstructured":"Vang, L., Morello, C.S., Mendy, J., Thompson, D., Manayani, D., Guenther, B., Julander, J., Sanford, D., Jain, A., Patel, A., et al. (2021). Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus. PLoS Negl Trop Dis 15, e0009195.","journal-title":"PLoS Negl Trop Dis"},{"key":"2851_CR81","doi-asserted-by":"publisher","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","volume":"8","author":"Q Wang","year":"2016","unstructured":"Wang, Q., Yang, H., Liu, X., Dai, L., Ma, T., Qi, J., Wong, G., Peng, R., Liu, S., Li, J., et al. (2016). Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci Transl Med 8, 369ra179.","journal-title":"Sci Transl Med"},{"key":"2851_CR82","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/v12050519","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Uraki, R., Hwang, J., and Fikrig, E. (2020). TRiC\/CCT complex, a binding partner of NS1 protein, supports the replication of Zika virus in both mammalians and mosquitoes. Viruses 12, 519.","journal-title":"Viruses"},{"key":"2851_CR83","doi-asserted-by":"publisher","first-page":"taae062","DOI":"10.1093\/jtm\/taae062","volume":"31","author":"J Wardle","year":"2024","unstructured":"Wardle, J., Bhatia, S., Cori, A., and Nouvellet, P. (2024). Temporal variations in international air travel: implications for modelling the spread of infectious diseases. J Travel Med 31, taae062.","journal-title":"J Travel Med"},{"key":"2851_CR84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","volume":"130","author":"SC Weaver","year":"2016","unstructured":"Weaver, S.C., Costa, F., Garcia-Blanco, M.A., Ko, A.I., Ribeiro, G.S., Saade, G., Shi, P. Y., and Vasilakis, N. (2016). Zika virus: history, emergence, biology, and prospects for control. Antiviral Res 130, 69\u201380.","journal-title":"Antiviral Res"},{"key":"2851_CR85","doi-asserted-by":"publisher","first-page":"102056","DOI":"10.1016\/j.omtn.2023.102056","volume":"34","author":"DK Wijesundara","year":"2023","unstructured":"Wijesundara, D.K., Yeow, A., McMillan, C.L.D., Choo, J.J.Y., Todorovic, A., Mekonnen, Z.A., Masavuli, M.G., Young, P.R., Gowans, E.J., Grubor-Bauk, B., et al. (2023). Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine. Mol Ther Nucleic Acids 34, 102056.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2851_CR86","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ebiom.2017.01.008","volume":"16","author":"SJ Wong","year":"2017","unstructured":"Wong, S.J., Furuya, A., Zou, J., Xie, X., Dupuis Ii, A.P., Kramer, L.D., and Shi, P.Y. (2017). A multiplex microsphere immunoassay for Zika virus diagnosis. EBioMedicine 16, 136\u2013140.","journal-title":"EBioMedicine"},{"key":"2851_CR87","doi-asserted-by":"publisher","first-page":"109308","DOI":"10.1016\/j.intimp.2022.109308","volume":"113","author":"G Xiong","year":"2022","unstructured":"Xiong, G., Li, Y., Chen, F., Xiong, X., Wang, Q., Zhang, L., Dong, H., Zhu, C., Cui, J., He, M., et al. (2022). Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E. Int Immunopharmacol 113, 109308.","journal-title":"Int Immunopharmacol"},{"key":"2851_CR88","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","volume":"7","author":"M Yang","year":"2017","unstructured":"Yang, M., Lai, H., Sun, H., and Chen, Q. (2017). Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Sci Rep 7, 7679.","journal-title":"Sci Rep"},{"key":"2851_CR89","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.vaccine.2020.12.077","volume":"39","author":"R Yang","year":"2021","unstructured":"Yang, R., Liu, Q., Pang, W., Gao, F., Liang, H., Zhang, W., Lin, Y., Li, M., Liu, Z., Gao, G.F., et al. (2021). Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques. Vaccine 39, 915\u2013925.","journal-title":"Vaccine"},{"key":"2851_CR90","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1126\/science.1153264","volume":"319","author":"IM Yu","year":"2008","unstructured":"Yu, I.M., Zhang, W., Holdaway, H.A., Li, L., Kostyuchenko, V.A., Chipman, P.R., Kuhn, R.J., Rossmann, M.G., and Chen, J. (2008). Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319, 1834\u20131837.","journal-title":"Science"},{"key":"2851_CR91","doi-asserted-by":"publisher","first-page":"104521","DOI":"10.1016\/j.meegid.2020.104521","volume":"85","author":"Y Zhan","year":"2020","unstructured":"Zhan, Y., Pang, Z., Du, Y., Wang, W., Yang, Y., Wang, W., Gao, G.F., Huang, B., Deng, Y., and Tan, W. (2020). NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge. Infect Genet Evol 85, 104521.","journal-title":"Infect Genet Evol"},{"key":"2851_CR92","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","volume":"166","author":"H Zhao","year":"2016","unstructured":"Zhao, H., Fernandez, E., Dowd, K.A., Speer, S.D., Platt, D.J., Gorman, M.J., Govero, J., Nelson, C.A., Pierson, T.C., Diamond, M.S., et al. (2016). Structural basis of Zika virus-specific antibody protection. Cell 166, 1016\u20131027.","journal-title":"Cell"},{"key":"2851_CR93","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/vaccines7030096","volume":"7","author":"Z Zhong","year":"2019","unstructured":"Zhong, Z., Portela Catani, J.P., Mc Cafferty, S., Couck, L., Van Den Broeck, W., Gorl\u00e9, N., Vandenbroucke, R.E., Devriendt, B., Ulbert, S., Cnops, L., et al. (2019). Immunogenicity and protection efficacy of a naked self-Replicating mRNA-based zika virus vaccine. Vaccines (Basel) 7, 96.","journal-title":"Vaccines (Basel)"},{"key":"2851_CR94","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1128\/JVI.02704-06","volume":"81","author":"Y Zhou","year":"2007","unstructured":"Zhou, Y., Ray, D., Zhao, Y., Dong, H., Ren, S., Li, Z., Guo, Y., Bernard, K.A., Shi, P.Y., and Li, H. (2007). Structure and function of flavivirus NS5 methyltransferase. J Virol 81, 3891\u20133903.","journal-title":"J Virol"},{"key":"2851_CR95","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2018.08.056","volume":"36","author":"J Zou","year":"2018","unstructured":"Zou, J., Xie, X., Luo, H., Shan, C., Muruato, A.E., Weaver, S.C., Wang, T., and Shi, P.Y. (2018). A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity. Ebiomedicine 36, 92\u2013102.","journal-title":"Ebiomedicine"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2851-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-024-2851-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2851-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:02:53Z","timestamp":1785744173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-024-2851-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":95,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2851"],"URL":"https:\/\/doi.org\/10.1007\/s11427-024-2851-4","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}